ALERS — Eurobio Scientific SA Share News
0.000.00%
Last trade - 00:00- €253.72m
- €241.20m
- €168.60m
French labs show how global supply bottlenecks thwart effort to ramp up testing
Brief: Eurobio Scientific Launches Rapid Diagnostic Test For SARS CoV-2 Virus Antigen Detection
Brief: Eurobio Scientific: CE Marking Of Its FluCoSyn EBX COVID PCR Test
Brief: Eurobio Scientific Buys TECOmedical, Expands In Europe
Brief: Eurobio Scientific: CNR Validates Two Covid-19 Serology Tests
Brief: Eurobio Scientific Confirms Proprietary PCR Test Is Part Of Fight Against COVID-19
Brief: Eurobio Scientific And NG Biotech Enter Into Marketing Agreement For COVID-19 Serology Rapid Tests
Brief: Eurobio Scientific FY EBITDA Up At 7.0 Million Euros
Brief: Eurobio Scientific Obtains CE Mark For Its Proprietary Covid-19 Test
Brief: Eurobio Scientific Secures 11 Million Euros Of Financing From Its Banking Pool
Brief: Eurobio Scientific Deploys Its Coronavirus Diagnostic Solutions
Brief: Eurobio Scientific: CE Marking Of Seegene Coronavirus Test
Brief: Eurobio Scientific Launches ALLPLEX CORONAVIRUS With Seegene
Brief: Eurobio Scientific Signs Contract For Development Of Proprietary Tests In Molecular Biology
Brief: Eurobio Scientific H1 EBITDA Up At 4.1 Million Euros
Brief: Eurobio Scientific H1 Revenue Rises To 29.5 Million Euros
Brief: Eurobio Scientific, Vivo Medical Group In Talks To Buy Pathway And Personal Diagnostics
Brief: Eurobio Scientific Enters Into Negotiations With Vivo Medical Group For Acquisition Of Two Companies In UK
Brief: Eurobio Scientific FY EBITDA Up At 5.0 Million Euros